NCT01051557 2021-07-19Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant GliomaNational Cancer Institute (NCI)Phase 1/2 Completed36 enrolled 15 charts
NCT00401011 2018-02-23Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma PatientsAEterna ZentarisPhase 1/2 Completed84 enrolled
NCT00399789 2018-02-22A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung CancerAEterna ZentarisPhase 1/2 Completed121 enrolled